NextImmune
NextImmune is a privately held biotechnology company.
NextImmune is a company in biotechnology, health care based in Europe, Middle East, and Africa (EMEA), founded in 2021.
Its activity falls under biotechnology, health care; the profile below is assembled from public directory data.
Europe, Middle East, and Africa (EMEA) is where the company is located.
The company is listed at the Grant stage of development.
Total disclosed funding stands at about $15K.
| Sector | Biotechnology, Health Care |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Stage | grant |
| Total funding | $150,000 |
Website: www.nextimmune.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account